MarketInOut Stock Screener Log In | Sign Up

Renascience Inc

TSE • Healthcare • Medical Devices • Quote as of 10/28/2026 15:30
Renascience Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeTSE
Market Capitalization13,680 mln
Float10.26 mln
Earnings Date05/14/2025

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.06
Reliable

Relative Strength

47 / 100
In line with market

Pre-Tax Margin

-460%
Severely loss-making

ROE

-12.97
Negative

Altman Z-Score

182
Exceptional

Business Description

Renascience Inc. is a Japanese pharmaceutical and medical device company founded in 2000 and based in Sendai. Its pipeline includes treatments for serious conditions such as certain cancers, lung diseases, hair loss, and hormonal disorders, with several candidates currently in early-stage clinical trials. The company is also working on a single-use ultra-thin endoscope and AI-powered diagnostic tools.

Key Fundamentals

EPS-24.09
ROE-12.97
RPS5.17
ROIC-317
ROA-12.39
EBITDA, mln-315
EV / EBITDA-40.99
EV / EBIT-40.99
Revenue, mln68.55
EV / Revenue189

Quote Details

Last 1,006.00
Change 23 (2.34%)
Open 989.00
Volume 168,500
Turnover 169,511,008
Average Volume 170,110

Financial Ratios

Pre-Tax Profit Margin-460
Leverage Ratio1.02
Current Ratio61.96
Price / Book4.98
Price / Tangible Book4.98
Price / Sales224

Financial Strength

Altman Z-Score182
Piotroski F-Score 3 / 9
Beneish M-Score-3.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.47% 41 / 100   
1 Month -17% 5 / 100   
2 Months -33.9% 2 / 100   
6 Months -24.64% 9 / 100   
1 Year -53.62% 2 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog